Ipamorelin

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameIpamorelin
Drug Alias Nameipamorelina伊帕瑞林ipamorelinum伊莫瑞林NNC-26-0161
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGhrelin/growth hormone secretagogue receptor agonists
TargetsGhrelin/growth hormone secretagogue receptor
Therapy Area/IndicationsGastrointestinal motility disordersIleus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHelsinn Therapeutics (U.S.) Inc
Active IndicationsN/A
Inactive IndicationsGastrointestinal motility disordersIleus

Other Information

ATC CodeN/A
Related LinksWikipedia